Oncology Pharma Inc
OTC:ONPH
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
Oncology Pharma Inc
OTC:ONPH
|
US |
|
OriginClear Inc
OTC:OCLN
|
US |
|
N
|
Network 1 Financial Group Inc
OTC:NTFL
|
US |
|
M
|
MDevice Co Ltd
KOSDAQ:226590
|
KR |
|
A
|
ABS Group Inc
OTC:MPRG
|
US |
|
C
|
Colgate-Palmolive (Pakistan) Ltd
KAR:COLG
|
PK |
|
CH Biotech R&D Co Ltd
TWSE:6534
|
TW |
|
A
|
Armada Acquisition Corp I
NASDAQ:AACI
|
US |
|
Portage Biotech Inc
NASDAQ:ATON
|
VG |
|
H
|
Hui Min Environmental Tech Corp
TPEX:6971
|
TW |
|
S
|
Sakurajima Futo Kaisha Ltd
TSE:9353
|
JP |
|
Nano Electronics and Micro System Technologies Inc
TWSE:7730
|
TW |
|
Warrior Gold Inc
XTSX:WAR
|
CA |
|
W
|
Waste Recovery Technology Inc
TPEX:6894
|
TW |
|
D
|
Delta Asia International Corp
TPEX:6762
|
TW |
Bankruptcy Probability
Oncology Pharma Inc's probability of bankruptcy is Hidden . The solvency score is Hidden .
We take all the information about a company's solvency, such as how easily it can pay interest on outstanding debt, how much cash it has, the amount of debt, and more, and use it to estimate the probability of bankruptcy.
Solvency Ratios
Solvency Ratios Comparison
Oncology Pharma Inc Competitors
| Country | Company | Market Cap | D/E | D/A |
Interest Coverage |
Altman Z-Score |
Quick Ratio |
Current Ratio |
Cash Ratio |
||
|---|---|---|---|---|---|---|---|---|---|---|---|
| US |
|
Oncology Pharma Inc
OTC:ONPH
|
1.6m USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| FR |
|
Pharnext SCA
OTC:PNEXF
|
6T USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| JP |
|
Takara Bio Inc
TSE:4974
|
120.4T JPY |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
|
Abbvie Inc
NYSE:ABBV
|
439.6B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
|
Amgen Inc
NASDAQ:AMGN
|
225.2B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
|
Gilead Sciences Inc
NASDAQ:GILD
|
168.6B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
|
Vertex Pharmaceuticals Inc
NASDAQ:VRTX
|
133.2B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
E
|
Epizyme Inc
F:EPE
|
94.1B EUR |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
|
Regeneron Pharmaceuticals Inc
NASDAQ:REGN
|
82.5B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| NL |
|
argenx SE
XBRU:ARGX
|
47.2B EUR |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| AU |
|
CSL Ltd
ASX:CSL
|
66.3B AUD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Oncology Pharma Inc's probability of bankruptcy is Hidden .
The probability of bankruptcy is estimated using credit risk models that assess financial health, debt levels, interest coverage, and other solvency indicators.
As of the latest report, Oncology Pharma Inc has total debt of 593.3k USD. This includes both short-term (237.5k USD) and long-term (355.8k USD) debt.
You can find a full breakdown on its Balance Sheet.
